Development and Comparison of Enzyme Immunoassays for Diagnosis of Chagas' Disease Using Fixed Forms of Trypanosoma cruzi (Epimastigotes, Amastigotes, and Trypomastigotes) and Assessment of Antigen Stability for the Three Assays

Journal of Clinical Microbiology

Volumn 42, Issue 4, 2004, Pages 1766-1769

  Berrizbietia, Mariolga ^a,b   Ndao, Momar ^a   Gottschalk, Marcelo ^b   Aché, Alberto ^c   Vásquez, Fabio ^a   Lacouture, Sonia ^b   Medina, Mehudy ^c   Ward, Brian J ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Ministerio del Poder Popular para la Salud   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

AMASTIGOTE; ANTIGEN DETECTION; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EPIMASTIGOTE; HUMAN; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; SCREENING; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VENEZUELA;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CANADA; CHAGAS DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI; VENEZUELA;

PROTOZOA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 16544390350     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.4.1766-1769.2004     Document Type: Article

References (37)

1. Ache, A., and A. J. Matos. 2001. Interrupting Chagas disease transmission in Venezuela. Rev. Inst. Med. Trop. Sao Paulo 43:37-43.
2. Almeida, I. C., D. T. Covas, L. M. Soussumi, and L. R. Travassos. 1997. A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 37:850-857.
3. Alves, M. J., G. Abuin, V. Y. Kuwajima, and W. Colli. 1986. Partial inhibition of trypomastigote entry into cultured mammalian cells by monoclonal antibodies against a surface glycoprotein of Trypanosoma cruzi. Mol. Biochem. Parasitol. 21:75-82.
4. Andrysiak, P. M., W. E. Collins, and G. H. Campbell. 1986. Concentration of Plasmodium ovale- and Plasmodium vivax-infected erythrocytes from non-human primate blood using Percoll gradients. Am. J. Trop. Med. Hyg. 35:251-254.
5. Antas, P. R., E. N. Azevedo, M. R. Luz, N. Medrano-Mercado, A. C. Chaves, P. G. Vidigal, A. C. Volpini, A. J. Romanha, and T. C. Araujo-Jorge. 2000. A reliable and specific enzyme-linked immunosorbent assay for the capture of IgM from human chagasic sera using fixed epimastigotes of Trypanosoma cruzi. Parasitol. Res. 86:813-820.
6. Araujo, F. G., and D. Guptill. 1984. Use of antigen preparations of the amastigote stage of Trypanosoma cruzi in the serology of Chagas' disease. Am. J. Trop. Med. Hyg. 33:362-371.
7. Aznar, C., P. Liegeard, C. Mariette, S. Lafon, M. J. Levin, and M. Hontebeyrie. 1997. A simple Trypanosoma cruzi enzyme-linked immunoassay for control of human infection in nonendemic areas. FEMS Immunol. Med. Microbiol. 18:31-37.
8. Botero, D., and M. Restrepo. 1992. Parasitosis humanas, 2nd ed. Corporación Para Investigaciones Biológicas, Medellín, Colombia.
9. Breniere, S. F., R. Carrasco, H. Miguez, J. L. Lemesre, and Y. Carlier. 1985. Comparisons of immunological tests for serodiagnosis of Chagas disease in Bolivian patients. Trop. Geogr. Med. 37:231-238.
10. Carbonetto, C. H., E. L. Malchiodi, M. G. Chiaramonte, N. W. Zwirner, and R. A. Margni. 1989. Use of formalinized epimastigotes for the detection of anti-Trypanosoma cruzi antibodies using immunoenzyme technics. Rev. Argent. Microbiol. 21:79-83. (In Spanish.)
11. Castilla, M. M., M. Santos-Gomez, C. Guzman-Bracho, and C. R. Bautista-Garfias. 1988. A new method for diagnosis of Chagas' disease: diffusion-ingel enzyme-linked immunosorbent assay. J. Parasitol. 74:805-809.
12. Cuna, W. R., C. Rodriguez, F. Torrico, D. Afchaln, M. Loyens, and P. Desjeux. 1989. Evaluation of a competitive antibody enzyme immunoassay for specific diagnosis of Chagas' disease. J. Parasitol. 75:357-359.
13. de Hubsch, R. M., N. Chiechie, G. Comach, R. R. Aldao, and R. D. Gusmao. 1989. The Dot immunoenzymatic assay on nitrocellulose (Dot-ELISA) in the diagnosis of Chagas disease. II. Seroepidemiologic study in 4 rural communities of Venezuela. Mem. Inst. Oswaldo Cruz 84:401-408. (In Portuguese.)
14. de Hubsch, R. M., N. Chiechie, G. Comach, R. Rangel Aldao, and R. D. Gusmao. 1988. Immunoenzyme assay using micro Dot on nitrocellulose (Dot-ELISA) in the diagnosis of Chagas' disease. I. Comparative study of 2 antigenic preparations of Trypanosoma cruzi. Mem. Inst. Oswaldo Cruz 83:277-285. (In Portuguese.)
15. Frank, M., B. Hegenscheid, K. Janitschke, and T. Weinke. 1997. Prevalence and epidemiological significance of Trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany. Infection 25:355-358.
16. Grant, I. H., J. W. Gold, M. Wittner, H. B. Tanowitz, C. Nathan, K. Mayer, L. Reich, N. Wollner, L. Steinherz, F. Ghavimi, et al. 1989. Transfusion-associated acute Chagas disease acquired in the United States. Ann. Intern. Med. 111:849-851.
17. Kanbara, H., and T. Nakabayashi. 1983. Improved method for separation on CM-cellulose of the trypomastigote form of Trypanosoma cruzi from forms grown in fibroblast cell cultures. Biken J. 26:63-65.
18. Leiby, D. A., R. M. Herron, Jr., E. J. Read, B. A. Lenes, and R. J. Stumpf. 2002. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 42:549-555.
19. Leiby, D. A., E. J. Read, B. A. Lenes, A. J. Yund, R. J. Stumpf, L. V. Kirchhoff, and R. Y. Dodd. 1997. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J. Infect. Dis. 176:1047-1052.
20. Lorca, M., A. Garcia, M. I. Bahamonde, A. Fritz, and R. Tassara. 2001. Serological certification of the interruption of the vectorial transmission of Chagas disease in Chile. Rev. Med. Chile 129:264-269. (In Spanish.)
21. Matsumoto, T. K., S. Hoshino-Shimizu, P. M. Nakamura, H. F. Andrade, Jr., and E. S. Umezawa. 1993. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease. J. Clin. Microbiol. 31:1486-1492.
22. Moncayo, A. 1999. Progress towards interruption of transmission of Chagas disease. Mem. Inst. Oswaldo Cruz 94:401-404.
23. Moncayo, A. 1999. Progress towards the interruption of transmission of Chagas disease in the southern countries. Medicina (Buenos Aires) 59:120-124. (In Spanish.)
24. Monteon, V. M., L. Guzman-Rojas, C. Negrete-Garcia, J. L. Rosales-Encina, and P. A. Lopez. 1997. Serodiagnosis of American trypanosomosis by using nonpathogenic trypanosomatid antigen. J. Clin. Microbiol. 35:3316-3319.
25. Nickerson, P., P. Orr, M. L. Schroeder, L. Sekla, and J. B. Johnston. 1989. Transfusion-associated Trypanosoma cruzi infection in a non-endemic area. Ann. Intern. Med. 111:851-853.
26. Oelemann, W. M., M. D. G. M. Teixeira, G. C. Verissimo Da Costa, J. Borges-Pereira, J. A. De Castro, J. R. Coura, and J. M. Peralta. 1998. Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease. J. Clin. Microbiol. 36:2423-2427.
27. Partel, C. D., and C. L. Rossi. 1998. A rapid, quantitative enzyme-linked immunosorbent assay (ELISA) for the immunodiagnosis of Chagas' disease. Immunol. Investig. 27:89-96.
28. Pinho, R. T., R. C. Pedrosa, P. Costa-Martins, and L. R. Castello-Branco. 1999. Saliva ELISA: a method for the diagnosis of chronic Chagas disease in endemic areas. Acta Trop. 72:31-38.
29. Rebeski, D. E., E. M. Winger, H. Okoro, S. Kowalik, H. J. Burger, D. E. Walters, M. M. Robinson, R. H. Dwinger, and J. R. Crowther. 2000. Detection of Trypanosoma congolense antibodies with indirect ELISAs using antigen-precoated microtitre plates. Vet. Parasitol. 89:187-198.
30. Rebeski, D. E., E. M. Winger, M. M. Robinson, C. M. Gabler, R. H. Dwinger, and J. R. Crowther. 2000. Evaluation of antigen-coating procedures of enzyme-linked immunosorbent assay method for detection of trypanosomal antibodies. Vet. Parasitol. 90:1-13.
31. Schechter, M. 1987. Evaluation of a monoclonal antibody affinity purified antigen for zymodeme specific serological diagnosis of Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz 82:81-85.
32. Schechter, M., and N. Nogueira. 1988. Variations induced by different methodologies in Trypanosoma cruzi surface antigen profiles. Mol. Biochem. Parasitol. 29:37-45.
33. Schmidt, G. D., and L. S. Roberts. 2000. Foundations of parasitology, 6th ed. McGraw-Hill Higher Education, New York, N.Y.
34. Schmunis, G. A. 1991. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries. Transfusion 31:547-557.
35. Silveira, A. C., and M. C. Vinhaes. 1999. Elimination of vectorial transmission of Chagas disease in Brazil. Medicina (Buenos Aires) 59:97-102. (In Spanish.)
36. Solana, M. E., A. M. Katzin, E. S. Umezawa, and C. S. Miatello. 1995. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease. J. Clin. Microbiol. 33:1456-1460.
37. Spencer, H. C., D. S. Allain, A. J. Sulzer, and W. E. Collins. 1980. Evaluation of the micro enzyme-linked immunosorbent assay for antibodies to Trypanosoma cruzi. Am. J. Trop. Med. Hyg. 29:179-182.